Key Market Indicators
Sales of blood and blood forming organs medicine in South Korea are expected to reach $2.4 billion by 2026, up from $2.2 billion in 2021. This amounts to a 1.5% year-on-year growth rate since 2013. In 2021, South Korea was in fourth place in terms of market size, overtaken by Italy, which had reached $2.2 billion. Germany, Italy and South Korea were the top three countries in this ranking. Hospital discharges for anemia in South Korea are forecast to increase to 15,410 by 2026, from 14,860 in 2021. This is a 0.6% year-on-year growth rate since 2010. In 2021, South Korea was in 11th place, with Hungary ahead on 14,860 hospital discharges. Germany, the United Kingdom and Poland were the top three countries in this ranking.
